• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-氯脱氧腺苷(克拉屈滨)对原代大鼠小胶质细胞的影响。

Effects of 2-chlorodeoxyadenosine (Cladribine) on primary rat microglia.

机构信息

Department of Neurology, Hannover Medical School Hannover, Hannover, Germany.

出版信息

J Neuroimmune Pharmacol. 2012 Dec;7(4):939-50. doi: 10.1007/s11481-012-9387-7. Epub 2012 Jul 21.

DOI:10.1007/s11481-012-9387-7
PMID:22821377
Abstract

2-chlorodeoxyadenosine (CdA, Cladribine) is an immunosuppressant that has recently been shown to be effective in the treatment of multiple sclerosis (MS). There is extensive clinical experience with CdA for the treatment of neoplastic diseases, especially hematologic malignancies, due to its apoptotic effects on leukemic and several other neoplastic cells. Furthermore, CdA crosses the blood-brain-barrier and thus may also exert its effects directly on cells of the central nervous system (CNS). Therefore, we have studied the effects of CdA on cultured primary rat microglia, the resident macrophage in the CNS, which is also thought to be involved in the pathogenesis of MS. Treatment of microglia with CdA inhibited their proliferation and induced apoptosis. Phosphorylation of CdA to CdATP was required for both effects and was inhibited by deoxycytidine. Furthermore, activation of caspase-3 and -9 revealed the involvement of the intrinsic mitochondrial mediated apoptotic pathway. However, the absence of caspase-8 activation specified independency from the extrinsic death receptor mediated apoptosis. The mitochondrial membrane potential was significantly reduced after CdA exposure and was not conserved with Bax or caspase-3 inhibition. Assessment of DNA fragmentation by TUNEL and DNA-release-assay showed microglia with fragmented nuclei. Other functions of microglia like phagocytosis and LPS-induced NO and TNF-α release were not affected by CdA. These data suggest a potential of CdA treatment to induce not only leukopenia but also apoptosis in microglia in the CNS. These results help to understand the mechanism of action of CdA in CNS diseases and may open the possibility to target microglia.

摘要

2-氯脱氧腺苷(CdA,克拉屈滨)是一种免疫抑制剂,最近已被证明对多发性硬化症(MS)的治疗有效。由于其对白血病和其他几种肿瘤细胞的凋亡作用,CdA 在治疗肿瘤疾病方面已有广泛的临床经验,特别是血液系统恶性肿瘤。此外,CdA 可穿过血脑屏障,因此也可能直接对中枢神经系统(CNS)的细胞发挥作用。因此,我们研究了 CdA 对培养的原代大鼠小胶质细胞的作用,小胶质细胞是 CNS 中的常驻巨噬细胞,也被认为与 MS 的发病机制有关。CdA 处理小胶质细胞可抑制其增殖并诱导其凋亡。磷酸化 CdA 为 CdATP 是这两种作用所必需的,并且被脱氧胞苷抑制。此外,caspase-3 和 -9 的激活表明涉及内在的线粒体介导的凋亡途径。然而,caspase-8 激活的缺失指定了不依赖于外在的死亡受体介导的凋亡。CdA 暴露后线粒体膜电位显著降低,并且不能与 Bax 或 caspase-3 抑制相保守。通过 TUNEL 和 DNA 释放测定评估 DNA 片段化显示小胶质细胞具有碎片化的核。小胶质细胞的其他功能,如吞噬作用和 LPS 诱导的 NO 和 TNF-α 释放不受 CdA 影响。这些数据表明 CdA 治疗不仅可能诱导白细胞减少,而且可能诱导 CNS 中小胶质细胞的凋亡。这些结果有助于理解 CdA 在 CNS 疾病中的作用机制,并可能为靶向小胶质细胞开辟可能性。

相似文献

1
Effects of 2-chlorodeoxyadenosine (Cladribine) on primary rat microglia.2-氯脱氧腺苷(克拉屈滨)对原代大鼠小胶质细胞的影响。
J Neuroimmune Pharmacol. 2012 Dec;7(4):939-50. doi: 10.1007/s11481-012-9387-7. Epub 2012 Jul 21.
2
2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.2-氯脱氧腺苷(克拉屈滨)诱导人单核细胞来源的树突状细胞凋亡。
Clin Exp Immunol. 2013 Aug;173(2):288-97. doi: 10.1111/cei.12109.
3
Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release.
Blood. 2002 Jan 15;99(2):655-63. doi: 10.1182/blood.v99.2.655.
4
Cladribine modifies functional properties of microglia.克拉屈滨可修饰小胶质细胞的功能特性。
Clin Exp Immunol. 2020 Sep;201(3):328-340. doi: 10.1111/cei.13473. Epub 2020 Jul 6.
5
2-Chloro-2'-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop.2-氯-2'-脱氧腺苷诱导T白血病细胞凋亡是通过半胱天冬酶-3依赖性线粒体反馈放大环介导的。
Int J Oncol. 2008 Jun;32(6):1325-33. doi: 10.3892/ijo_32_6_1325.
6
Dichlorvos exposure results in activation induced apoptotic cell death in primary rat microglia.敌敌畏暴露导致原代大鼠小胶质细胞激活诱导的细胞凋亡死亡。
Chem Res Toxicol. 2012 Aug 20;25(8):1762-70. doi: 10.1021/tx300234n. Epub 2012 Aug 3.
7
2-Chlorodeoxyadenosine (Cladribine) preferentially inhibits the biological activity of microglial cells.2-氯脱氧腺苷(克拉屈滨)优先抑制小胶质细胞的生物学活性。
Int Immunopharmacol. 2022 Apr;105:108571. doi: 10.1016/j.intimp.2022.108571. Epub 2022 Jan 29.
8
Mechanism of action of pentostatin and cladribine in hairy cell leukemia.喷司他丁和克拉屈滨在毛细胞白血病中的作用机制。
Leuk Lymphoma. 2011 Jun;52 Suppl 2:43-5. doi: 10.3109/10428194.2011.570394. Epub 2011 Apr 4.
9
Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways.促红细胞生成素通过调节小胶质细胞、Akt1、Bad和半胱天冬酶介导的途径,促进内在和外在的神经元保护。
Br J Pharmacol. 2003 Mar;138(6):1107-18. doi: 10.1038/sj.bjp.0705161.
10
Synthesis and Functional Investigations of Computer Designed Novel Cladribine-Like Compounds for the Treatment of Multiple Sclerosis.新型克拉屈滨类似物的计算机设计、合成及功能研究用于多发性硬化症的治疗。
Arch Pharm (Weinheim). 2017 Nov;350(11). doi: 10.1002/ardp.201700185. Epub 2017 Sep 28.

引用本文的文献

1
Microglial Mayhem NLRP3 Inflammasome's Role in Multiple Sclerosis Pathology.小胶质细胞的破坏:NLRP3炎性小体在多发性硬化症病理中的作用
CNS Neurosci Ther. 2024 Dec;30(12):e70135. doi: 10.1111/cns.70135.
2
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis.多发性硬化症的中枢神经系统疾病修饰治疗的生物利用度。
Front Immunol. 2023 Nov 29;14:1290666. doi: 10.3389/fimmu.2023.1290666. eCollection 2023.
3
Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.

本文引用的文献

1
Decreased microglial activation in MS patients treated with glatiramer acetate.使用醋酸格拉替雷治疗的 MS 患者的小胶质细胞活化减少。
J Neurol. 2012 Jun;259(6):1199-205. doi: 10.1007/s00415-011-6337-x. Epub 2011 Dec 9.
2
Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?脱髓鞘和髓鞘再生过程中小胶质细胞的特征:它们能否创造一个有利于修复的环境?
Neurobiol Dis. 2012 Jan;45(1):519-28. doi: 10.1016/j.nbd.2011.09.008. Epub 2011 Sep 21.
3
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
鞘氨醇 1 受体调节剂及其他多发性硬化症治疗药物的分子神经免疫药理学
Pharmacol Ther. 2023 Jun;246:108432. doi: 10.1016/j.pharmthera.2023.108432. Epub 2023 May 4.
4
Cytokine Secretion Dynamics of Isolated PBMC after Cladribine Exposure in RRMS Patients.RRMS 患者经克拉屈滨处理后分离的 PBMC 的细胞因子分泌动力学。
Int J Mol Sci. 2022 Sep 6;23(18):10262. doi: 10.3390/ijms231810262.
5
Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration Acutely Influences Monocyte Differentiation but Not Microglial Activation.克拉屈滨治疗多发性硬化症可保留随后生成的单核细胞的分化能力,而其给药则急性影响单核细胞分化但不影响小胶质细胞激活。
Front Immunol. 2022 Jun 6;13:678817. doi: 10.3389/fimmu.2022.678817. eCollection 2022.
6
Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.进展性多发性硬化症中的中枢神经系统巨噬细胞:与神经退行性变和治疗的关系。
J Neuroinflammation. 2022 Feb 10;19(1):45. doi: 10.1186/s12974-022-02408-y.
7
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis.基于机制的标准来改善进展性多发性硬化症的治疗效果。
Nat Rev Neurol. 2022 Jan;18(1):40-55. doi: 10.1038/s41582-021-00581-x. Epub 2021 Nov 3.
8
The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.不同巨噬细胞亚群在 MS 发病机制中的作用以及不同治疗药物对这些群体的影响。
Front Immunol. 2021 Aug 20;12:667705. doi: 10.3389/fimmu.2021.667705. eCollection 2021.
9
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review.克拉屈滨片治疗多发性硬化症的研究进展:全面综述。
Drugs. 2020 Dec;80(18):1901-1928. doi: 10.1007/s40265-020-01422-9.
10
Cladribine modifies functional properties of microglia.克拉屈滨可修饰小胶质细胞的功能特性。
Clin Exp Immunol. 2020 Sep;201(3):328-340. doi: 10.1111/cei.13473. Epub 2020 Jul 6.
CLARITY 研究中用克拉屈滨片治疗的复发缓解型多发性硬化患者的持续疾病活动状态无进展:一项事后和亚组分析。
Lancet Neurol. 2011 Apr;10(4):329-37. doi: 10.1016/S1474-4422(11)70023-0.
4
Glatiramer acetate modulates TNF-α and IL-10 secretion in microglia and promotes their phagocytic activity.醋酸格拉替雷调节小胶质细胞中 TNF-α 和 IL-10 的分泌,并促进其吞噬活性。
J Neuroimmune Pharmacol. 2011 Sep;6(3):381-8. doi: 10.1007/s11481-010-9248-1. Epub 2010 Nov 3.
5
Anti-apoptosis and cell survival: a review.抗凋亡与细胞存活:综述
Biochim Biophys Acta. 2011 Jan;1813(1):238-59. doi: 10.1016/j.bbamcr.2010.10.010. Epub 2010 Oct 20.
6
Mitochondria and cell death: outer membrane permeabilization and beyond.线粒体与细胞死亡:外膜通透及其他
Nat Rev Mol Cell Biol. 2010 Sep;11(9):621-32. doi: 10.1038/nrm2952. Epub 2010 Aug 4.
7
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.一项口服克拉屈滨治疗复发型多发性硬化的安慰剂对照试验。
N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20.
8
Role of microglia in neuronal degeneration and regeneration.小胶质细胞在神经元变性和再生中的作用。
Semin Immunopathol. 2009 Nov;31(4):513-25. doi: 10.1007/s00281-009-0180-5. Epub 2009 Sep 9.
9
Progressive multiple sclerosis.进行性多发性硬化。
Semin Immunopathol. 2009 Nov;31(4):455-65. doi: 10.1007/s00281-009-0182-3.
10
Enhanced microglial clearance of myelin debris in T cell-infiltrated central nervous system.T细胞浸润的中枢神经系统中,小胶质细胞对髓鞘碎片的清除作用增强。
J Neuropathol Exp Neurol. 2009 Aug;68(8):845-56. doi: 10.1097/NEN.0b013e3181ae0236.